| Trait Information | |
| Identifier | MONDO_0020753 |
| Description | Infectious disease causes by viruses in the subfamily Orthocoronavirinae (coronaviruses). In humans, coronaviruses cause respiratory tract infections that can be mild, such as some cases of the common cold (among other possible causes, predominantly rhinoviruses), and others that can be lethal, such as SARS, MERS, and COVID-19. [Wikipedia: Coronavirus] | Trait category |
Other trait
|
| Synonyms |
2 synonyms
|
| Child trait(s) | COVID-19 |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS002272 (GRS6_COVID) |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
COVID-19 infection | COVID-19 | 6 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002272/ScoringFiles/PGS002272.txt.gz |
| PGS002273 (GRS12_COVID) |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
COVID-19 infection | COVID-19 | 12 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002273/ScoringFiles/PGS002273.txt.gz |
| PGS004938 (pgs_data_ldpred) |
PGP000666 | Kovalenko E et al. Front Med (Lausanne) (2024) |
Severe COVID-19 course | COVID-19 | 955,503 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004938/ScoringFiles/PGS004938.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM012926 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.38 [1.26, 1.53] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012927 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | — | OR (top 10% vs rest of population): 1.58 [1.36, 1.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012928 | PGS002272 (GRS6_COVID) |
PSS009623| African Ancestry| 2,598 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.7 [1.03, 2.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012929 | PGS002272 (GRS6_COVID) |
PSS009625| Hispanic or Latin American Ancestry| 3,752 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.56 [1.0, 2.43] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012930 | PGS002272 (GRS6_COVID) |
PSS009626| South Asian Ancestry| 760 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.42 [0.72, 2.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012933 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 1.39 [1.23, 1.56] | — | High clinical risk included indiviiduals with any of the following criteria: age≥65, BMI≥35, chronic kidney disease, diabetes, immunosuppressive disease, or age ≥55 and presence of chronic obstructive pulmonary disease, cardiovascular disease, or hypertension |
| PPM012934 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 1.65 [1.39, 1.96] | — | High clinical risk included indiviiduals with any of the following criteria: age≥65, BMI≥35, chronic kidney disease, diabetes, immunosuppressive disease, or age ≥55 and presence of chronic obstructive pulmonary disease, cardiovascular disease, or hypertension |
| PPM012935 | PGS002272 (GRS6_COVID) |
PSS009625| Hispanic or Latin American Ancestry| 3,752 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 3.35 [1.56, 7.2] | — | — |
| PPM012936 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.659 [0.639, 0.679] | — | age, sex, PCs | — |
| PPM012937 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.708 [0.688, 0.727] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
| PPM012938 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.696 [0.668, 0.723] | — | age, sex, PCs | — |
| PPM012939 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.75 [0.723, 0.776] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
| PPM012940 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.744 [0.731, 0.756] | — | age, sex, PCs | — |
| PPM012941 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.766 [0.753, 0.778] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
| PPM012942 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.796 [0.777, 0.815] | — | age, sex, PCs | — |
| PPM012943 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.814 [0.769, 0.832] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
| PPM012931 | PGS002273 (GRS12_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.38 [1.26, 1.52] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM012932 | PGS002273 (GRS12_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | — | OR (top 10% vs rest of population): 1.64 [1.43, 1.9] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
| PPM021730 | PGS004938 (pgs_data_ldpred) |
PSS011763| European Ancestry| 7,124 individuals |
PGP000666 | Kovalenko E et al. Front Med (Lausanne) (2024) |
Reported Trait: Severe COVID-19 course | — | AUROC: 0.6 | Odds ratio (OR, high vs low tertile): 2.25 | PC1-20, sex, gender | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009621 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 25,353 individuals | — | European | — | AncestryDNA | — |
| PSS009622 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 14,320 individuals | — | European | — | UKB | — |
| PSS009623 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 2,598 individuals | — | African unspecified | — | AncestryDNA, MyCode, UKB | Meta-analysis |
| PSS009624 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 44,958 individuals | — | European | — | AncestryDNA, MyCode, UKB | Meta-analysis |
| PSS009625 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 3,752 individuals | — | Hispanic or Latin American | — | AncestryDNA, MyCode, UKB | Meta-analysis |
| PSS009626 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 760 individuals | — | South Asian | — | AncestryDNA, MyCode, UKB | Meta-analysis |
| PSS011763 | Very severe respiratory confirmed covid vs. not severe respiratory confirmed covid | — | [
|
— | European | — | Genotek | — |